Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins

Infection and Immunity

Volumn 69, Issue 11, 2001, Pages 6612-6617

  Schenkein, H A ^a   Berry, C R ^a   Purkall, D ^a   Burmeister, J A ^a   Brooks, C N ^a   Tew, J G ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; PARAPROTEIN; PHOSPHORYLCHOLINE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; ATHEROSCLEROSIS; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HAEMOPHILUS APHROPHILUS; HUMAN; IMMUNOSTIMULATION; INFLAMMATION; MOUSE; MOUTH FLORA; NONHUMAN; PERIODONTAL DISEASE; PRIORITY JOURNAL; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SANGUINIS; TOOTH PLAQUE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ACTINOMYCES; ANTIBODIES, BACTERIAL; BACTERIA; CROSS REACTIONS; DENTAL PLAQUE; FUSOBACTERIUM NUCLEATUM; HAEMOPHILUS; HUMANS; LIPOPROTEINS, LDL; PHOSPHORYLCHOLINE; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SANGUIS;

EID: 0034778925     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.11.6612-6617.2001     Document Type: Article

References (52)

1. Naturally occurring antibodies to cholesterol: A new theory of LDL cholesterol metabolism
2. Association between extent of periodontal attachment loss and self-reported history of heart attack: An analysis of NHANES III data
3. Periodontal disease and cardiovascular disease
4. Periodontitis: A risk factor for coronary heart disease?
5. Dental infections and atherosclerosis
6. Epidemiology of periodontal diseases
7. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM
8. Subpopulations of antibodies to phosphocholine in human serum
9. ELISA of IgG antibody to oxidized low-density lipoprotein: Effects of blocking buffer and method of data expression
10. Invasion of human coronary artery cells by periodontal pathogens
11. Autoimmunity in atherosclerosis: Lessons from experimental models
12. Autoimmunity in atherosclerosis. The role of autoantigens
13. Phosphorylcholine-containing antigens in bacteria from the mouth and respiratory tract
14. Species of alpha-hemolytic streptococci possessing a C-polysaccharide phosphorylcholine-containing antigen
15. Dominant cross-reactive antibodies generated during the response to a variety of oral bacterial species detect phosphorylcholine
16. Identification of periodontal pathogens in atheromatous plaques
17. Phosphorylcholine: Friend or foe of the immune system?
18. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
19. Immunological responses to oxidized LDL
20. Periodontal disease and coronary heart disease risk
21. Circulating antibodies recognizing oxidatively modified low-density lipoprotein in children
22. Immune recognition of OxLDL in atherosclerosis
23. Detection of the phosphorylcholine epitope in streptococci. Haemophilus and pathogenic Neisseriae by immunoblotting
24. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease
25. Cytokines, modified lipoproteins, and arteriosclerosis in diabetes
26. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus
27. Protein measurement with the Folin phenol reagent
28. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: A biochemical signature of an enhanced in vivo low-density lipoprotein oxidation
29. Antiphospholipid antibodies and atherosclerosis
30. Oral pathogens: From dental plaque to cardiac disease
31. Anti-modified LDL antibodies. LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes
32. Choline-containing teichoic acid as a structural component of pneumococcal cell wall and its role in sensitivity to lysis by an autolytic enzyme
33. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma
34. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis
35. Porphyromonas gingivalis virulence factors and invasion of cells of the cardiovascular system
36. Antibody against oxidized low-density lipoprotein predicting myocardial infarction
37. Lipoprotein(a) oxidation and autoantibodies: A new path in atherothrombosis
38. Autoantibody against oxidised LDL and progression of carotid atherosclerosis
39. Invasion of human vascular endothelial cells by Actinobacillus actinomycetemcomitans via the receptor for platelet-activating factor
40. Antiphosphorylcholine antibody levels are elevated in humans with periodontal diseases
41. Autoantibodies to markers of oxidative stress are elevated in women with endometriosis
42. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity
43. Neo-self antigens and the expansion of B-1 cells: Lessons from atherosclerosis-prone mice
44. Acute-phase inflammatory response to periodontal disease in the US population
45. The effect of smoking on serum IgG2 reactive with Actinobacillus actinomycetemcomitans in early-onset periodontitis patients
46. Antibodies against copper-oxidised and malondialdehyde-modified low density lipoproteins in pre-eclampsia pregnancies
47. Antibodies to oxidised LDL
48. Antiphospholipid antibodies and myocardial infarction
49. Autoantibodies to modified LDLs and other phospholipid-protein complexes as markers of cardiovascular diseases
50. Periodontal disease and risk of cerebrovascular disease: The first national health and nutrition examination survey and its follow-up study
51. Examination of the relation between periodontal health status and cardiovascular risk factors: Serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen
52. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis